This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
PLAINSBORO, N.J., Oct. 8, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) today announced that it is featuring its new MAYFIELD
® Composite Series Cranial Stabilization products at the Congress of Neurological Surgeons (CNS) annual meeting, October 6 – 10, 2012, in Chicago, Illinois. The MAYFIELD
® Composite Series products provide rigid skeletal fixation of a patient's skull during many standard neurological procedures. Included in these products is a new MAYFIELD
® Skull Clamp that has received 510(k) clearance from the United States Food and Drug Administration (FDA) and CE Mark Certification in the European Union.
The Composite Series products are ideal for standard neurological procedures, including craniotomies, biopsies, and any procedures where rigid skeletal fixation is required but intra-operative imaging modalities are not used. The new products have been engineered using hybrid composite materials for more durability, rigidity and endurance, especially with regards to the emerging emphasis on decontamination of the products for the safety of both the patient and the hospital staff. The time-tested design of the new base unit and the skull clamp has been engineered with materials and finishes that can withstand the high temperatures and harsh chemicals required for decontamination. They can also withstand the protocol for decontamination of highly infectious diseases as outlined in the World Health Organization (WHO) Infection Control Guidelines for Transmissible Spongiform Encephalopathies (Switzerland, March 1999).
"The new MAYFIELD
® Composite Series products continue the MAYFIELD
® heritage of surgeon-designed and surgeon-trusted cranial stabilization products. These new products reflect Integra's dedication to innovation and leadership in cranial stabilization," said Pete Ligotti, Vice President of Marketing, Neurosurgery.
The Composite Series products include a new MAYFIELD
® Skull Clamp, along with a more robust MAYFIELD
® Base Unit that also now includes a MAYFIELD
® Swivel Adaptor. The Base Unit is constructed with improved rigidity and strength, all while retaining the highly versatile and maneuverable features for the benefit of optimal patient positioning. The Base Unit is now equipped with an improved locking handle for easier opening and closing, along with a locking latch for improved safety. No tools are required for the adjustment of the locking handle or for fitting the base unit to the OR table. A MAYFIELD
® Tri-Star Swivel Adaptor is available for image-guided surgery procedures when ancillary components are required.
® cranial stabilization product line was started by world renowned neurosurgeon, Dr. Frank H. Mayfield, over 40 years ago. MAYFIELD
® cranial stabilization systems are used in over 200,000 brain procedures in the U.S. annually, including treatment of head trauma injuries, pediatric disorders such as hydrocephalus, and biopsies and cancer removal.
"The new MAYFIELD
® Composite Series products provide our valued customers with the rigid platform required for delicate neurosurgical procedures," stated Mark Budde, Senior Marketing Director, Neurosurgery. "The enhanced MAYFIELD
® cranial stabilization products exhibit our commitment to provide products and support that help our customers limit uncertainty in their daily practice of neurosurgery."
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Integra products may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2011 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.